Cadence OTC Announces Community Investment Campaign to Support the Movement for Accessible Birth Control in Post-Roe America

×

Error message

  • Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).

Cadence OTC , a pioneering public benefits consumer healthcare company, has passionately pursued the vision of accessible over-the-counter (OTC) birth control pills.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Thursday, March 28, 2024
Information
Tags: 
Teens, Women, FDA, Convenience Store, Other Health, Health, Consumer, Pharmaceutical, Retail, Birth, Woman, Condom, Partnership, George Soros, Education, 7-Eleven, MAP, OTC, Food, Birth control
Geotags: 
UNITED STATES, NORTH AMERICA, CALIFORNIA
Organisation: 
CADENCE OTC
Summary
Key Points: 
  • Cadence OTC , a pioneering public benefits consumer healthcare company, has passionately pursued the vision of accessible over-the-counter (OTC) birth control pills.
  • The campaign invites the public to champion affordable, accessible birth control and make a heartfelt investment in women's reproductive autonomy.
  • Samantha Miller, co-founder and co-CEO of Cadence OTC, asserts, “Birth control should be as easy to buy as condoms.
  • To be part of this historic movement in reproductive care and for more information on Cadence OTC, visit https://wefunder.com/cadenceotc/ .


Cadence OTC, a pioneering public benefits consumer healthcare company, has passionately pursued the vision of accessible over-the-counter (OTC) birth control pills. Today marks an exciting development in this journey, as Cadence OTC unveils a community investment round on Wefunder, a platform that allows individuals to invest in startups. The campaign invites the public to champion affordable, accessible birth control and make a heartfelt investment in women's reproductive autonomy.

In the United States, the pressing issue of 2.3 million unintended pregnancies each year underscores the critical need for accessible contraception. For over six decades, the path to obtaining birth control pills has remained confined behind prescription barriers. Cadence OTC is at the forefront of a revolution in reproductive health, advocating for accessibility and affordability. Their collaboration with the U.S. Food and Drug Administration (FDA) is working to bring forth a combination oral contraceptive pill available over the counter without a prescription. If approved, the FDA provides 3 years of market exclusivity for Cadence’s product category within a total addressable market of more than $9 billion. Cadence's innovative efforts have already materialized in the first emergency contraceptive – Morning After Pill (MAP) – now accessible through our partnership with the #1 distributor of healthcare products across over 150,000 convenience stores nationwide, like 7-Eleven.

Samantha Miller, co-founder and co-CEO of Cadence OTC, asserts, “Birth control should be as easy to buy as condoms. We are committed to removing the hurdles in accessing contraception, enabling women to take charge of their reproductive decisions any time, any place. This community investment opportunity invites everyone who supports equity in contraceptive access to join us in this transformative journey, investing in a future where birth control is within everyone’s easy reach.”

The Wefunder campaign is a community-building initiative running in parallel with Cadence OTC's core fundraising effort, spearheaded by the Soros Economic Development Fund. The company has already garnered more than $35 million in support from investors like RH Capital, NJF Capital, Elizabeth Banks, Abigail Disney, and the Global Fund for Women. This funding will propel the commercial expansion of Morning After Pill (MAP) in convenience stores nationwide, launch its ultra-sensitive pregnancy test, and most importantly, support the final steps toward making its OTC birth control pill a reality.

Dr. Nap Hosang, co-founder, co-CEO, and chief medical officer of Cadence OTC emphasizes, “Investing is not just for the affluent; we’re democratizing it to empower those committed to improving contraceptive access. The consequences of unintended pregnancies are profound, affecting education, economic stability, and health. The time is now to revolutionize our outdated birth control access methods.”

The Cadence OTC community funding round is open to all on the Wefunder platform, with a minimum investment of $250, and investor perks beginning at a $500 investment level. To be part of this historic movement in reproductive care and for more information on Cadence OTC, visit https://wefunder.com/cadenceotc/.

About Cadence OTC: Cadence OTC is a Public Benefits consumer healthcare company headquartered in Oakland, CA, on a mission to enhance over-the-counter (OTC) access to safe, effective, and affordable contraceptives for everyone, everywhere. Cadence holds rights to three of the most popular oral contraceptive formulations and is actively working towards moving The Pill from prescription to over-the-counter. Additionally, the company is making history by introducing an OTC emergency contraceptive to convenience stores nationwide. Founded and led by renowned reproductive health experts, experienced healthcare entrepreneurs, and passionate supporters, Cadence OTC is committed to ensuring equal accessibility to birth control for all individuals. Learn more at www.cadenceotc.com.

Copyright: 
Copyright Business Wire 2024